Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
Details for Australian Patent Application No. 2009286380 (hide)
International Classifications
Event Publications
3 March 2011 PCT application entered the National Phase
PCT publication WO2010/023594 Priority application(s): WO2010/023594
17 March 2011 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name Pfizer Inc., Application No. 2009286380, under INID (54) correct the title to read Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
15 September 2011 Application Accepted
Published as AU-B-2009286380
19 January 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009286377-Respiratory drug delivery apparatus which provides audio instructions
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser